Cellular and extracellular matrix changes in anterior cruciate ligaments during human knee aging and osteoarthritis

Arthritis Research and Therapy

Volumn 15, Issue 1, 2013, Pages

  Hasegawa, Akihiko ^a,b   Nakahara, Hiroyuki ^a   Kinoshita, Mitsuo ^b   Asahara, Hiroshi ^a   Koziol, James ^a   Lotz, Martin K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; STRO 1 PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; AUTOPSY; CARTILAGE CELL; CELL AGGREGATION; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CYTOPATHOLOGY; DEGENERATION; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE OSTEOARTHRITIS; METAPLASIA; MYOFIBROBLAST; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; STEM CELL; ARTICULAR CARTILAGE; CADAVER; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTERIOR CRUCIATE LIGAMENT; BLOTTING, WESTERN; CADAVER; CARTILAGE, ARTICULAR; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; YOUNG ADULT;

EID: 84873600194     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4165     Document Type: Article

References (41)

1. Hasegawa A, Otsuki S, Pauli C, Miyaki S, Patil S, Steklov N, Kinoshita M, Koziol J, D'Lima DD, Lotz MK. Anterior cruciate ligament changes in the human knee joint in aging and osteoarthritis. Arthritis Rheum 2012, 64:696-704. 10.1002/art.33417, 3266452, 22006159.
2. Mullaji AB, Marawar SV, Simha M, Jindal G. Cruciate ligaments in arthritic knees: a histologic study with radiologic correlation. J Arthroplasty 2008, 23:567-572. 10.1016/j.arth.2007.05.024, 18514876.
3. Murray MM, Spector M. Fibroblast distribution in the anteromedial bundle of the human anterior cruciate ligament: the presence of alpha-smooth muscle actin-positive cells. J Orthop Res 1999, 17:18-27. 10.1002/jor.1100170105, 10073643.
4. Murray MM, Weiler A, Spindler KP. Interspecies variation in the fibroblast distribution of the anterior cruciate ligament. Am J Sports Med 2004, 32:1484-1491. 10.1177/0363546504263700, 15310575.
5. Narama I, Masuoka-Nishiyama M, Matsuura T, Ozaki K, Nagatani M, Morishima T. Morphogenesis of degenerative changes predisposing dogs to rupture of the cranial cruciate ligament. J Vet Med Sci 1996, 58:1091-1097. 10.1292/jvms.58.11_1091, 8959657.
6. Vasseur PB, Pool RR, Arnoczky SP, Lau RE. Correlative biomechanical and histologic study of the cranial cruciate ligament in dogs. Am J Vet Res 1985, 46:1842-1854.
7. Cushner FD, La Rosa DF, Vigorita VJ, Scuderi GR, Scott WN, Insall JN. A quantitative histologic comparison: ACL degeneration in the osteoarthritic knee. J Arthroplasty 2003, 18:687-692. 10.1016/S0883-5403(03)00256-0, 14513440.
8. Murray MM, Martin SD, Martin TL, Spector M. Histological changes in the human anterior cruciate ligament after rupture. J Bone Joint Surg Am 2000, (82A):1387-1397.
9. Brune T, Borel A, Gilbert TW, Franceschi JP, Badylak SF, Sommer P. In vitro comparison of human fibroblasts from intact and ruptured ACL for use in tissue engineering. Eur Cell Mater 2007, 14:78-90. discussion 90-91.
10. Cheng MT, Yang HW, Chen TH, Lee OK. Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Prolif 2009, 42:448-460. 10.1111/j.1365-2184.2009.00611.x, 19489981.
11. Zhang J, Pan T, Im HJ, Fu FH, Wang JH. Differential properties of human ACL and MCL stem cells may be responsible for their differential healing capacity. BMC Med 2011, 9:68. 10.1186/1741-7015-9-68, 3126732, 21635735.
12. Steinert AF, Kunz M, Prager P, Barthel T, Jakob F, Noth U, Murray MM, Evans CH, Porter RM. Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells. Tissue Eng Part A 2011, 17:1375-1388. 10.1089/ten.tea.2010.0413, 3079172, 21247268.
13. Laurencin CT, Freeman JW. Ligament tissue engineering: an evolutionary materials science approach. Biomaterials 2005, 26:7530-7536. 10.1016/j.biomaterials.2005.05.073, 16045982.
14. Petersen W, Tillmann B. Structure and vascularization of the cruciate ligaments of the human knee joint. Anat Embryol (Berl) 1999, 200:325-334.
15. Corps AN, Robinson AH, Movin T, Costa ML, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006, 45:291-294.
16. Lo IK, Marchuk LL, Hart DA, Frank CB. Comparison of mRNA levels for matrix molecules in normal and disrupted human anterior cruciate ligaments using reverse transcription-polymerase chain reaction. J Orthop Res 1998, 16:421-428. 10.1002/jor.1100160405, 9747782.
17. Young K, Samiric T, Feller J, Cook J. Extracellular matrix content of ruptured anterior cruciate ligament tissue. Knee 2011, 18:242-246. 10.1016/j.knee.2010.05.008, 20719518.
18. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006, 97:33-44. 10.1002/jcb.20652, 16215986.
19. Brent AE, Schweitzer R, Tabin CJ. A somitic compartment of tendon progenitors. Cell 2003, 113:235-248. 10.1016/S0092-8674(03)00268-X, 12705871.
20. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 2001, 128:3855-3866.
21. Petschnik AE, Fell B, Kruse C, Danner S. The role of alpha-smooth muscle actin in myogenic differentiation of human glandular stem cells and their potential for smooth muscle cell replacement therapies. Expert Opin Biol Ther 2010, 10:853-861. 10.1517/14712591003769832, 20367528.
22. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
23. Benjamin M, Ralphs JR. Fibrocartilage in tendons and ligaments: an adaptation to compressive load. J Anat 1998, 193:481-494. 10.1046/j.1469-7580.1998.19340481.x, 1467873, 10029181.
24. Roos H, Adalberth T, Dahlberg L, Lohmander LS. Osteoarthritis of the knee after injury to the anterior cruciate ligament or meniscus: the influence of time and age. Osteoarthritis Cartilage 1995, 3:261-267. 10.1016/S1063-4584(05)80017-2, 8689461.
25. Fleming BC, Hulstyn MJ, Oksendahl HL, Fadale PD. Ligament injury, reconstruction and osteoarthritis. Curr Opin Orthop 2005, 16:354-362. 10.1097/01.bco.0000176423.07865.d2, 1948850, 17710194.
26. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010, 26:371-386. 10.1016/j.cger.2010.03.002, 2920876, 20699160.
27. Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease?. Best Pract Res Clin Rheumatol 2010, 24:15-26. 2818253, 20129196.
28. Kolettas E, Muir HI, Barrett JC, Hardingham TE. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology (Oxford) 2001, 40:1146-1156.
29. Tew SR, Li Y, Pothacharoen P, Tweats LM, Hawkins RE, Hardingham TE. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 2005, 13:80-89. 10.1016/j.joca.2004.10.011, 15639641.
30. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001, 13:721-727. 10.1016/S0955-0674(00)00276-3, 11698188.
31. Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, Olson EN. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 1995, 121:1099-1110.
32. Shukunami C, Takimoto A, Oro M, Hiraki Y. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 2006, 298:234-247. 10.1016/j.ydbio.2006.06.036, 16876153.
33. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192. 10.1634/stemcells.19-3-180, 11359943.
34. Caplan AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005, 11:1198-1211. 10.1089/ten.2005.11.1198, 16144456.
35. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347. 10.1002/jcp.21200, 17620285.
36. Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther 2010, 1:30. 10.1186/scrt30, 2983443, 20863417.
37. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004, 36:598-606. 10.1016/j.biocel.2003.10.005, 15010326.
38. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007, 257:143-179.
39. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503. 10.1002/path.1427, 12845617.
40. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998, 142:873-881. 10.1083/jcb.142.3.873, 2148176, 9700173.
41. Hayashi K, Frank JD, Hao Z, Schamberger GM, Markel MD, Manley PA, Muir P. Evaluation of ligament fibroblast viability in ruptured cranial cruciate ligament of dogs. Am J Vet Res 2003, 64:1010-1016. 10.2460/ajvr.2003.64.1010, 12926594.